Holen Sie sich die Stockscreener-App
5.01
1.01%
0.05
Handel nachbörslich:
5.01
Schlusskurs vom Vortag:
$4.96
Offen:
$5.04
24-Stunden-Volumen:
128.72K
Relative Volume:
0.45
Marktkapitalisierung:
$268.11M
Einnahmen:
$36.68M
Nettoeinkommen (Verlust:
$-36.78M
KGV:
-4.319
EPS:
-1.16
Netto-Cashflow:
$-26.75M
1W Leistung:
-11.33%
1M Leistung:
+12.58%
6M Leistung:
-10.38%
1J Leistung:
-8.07%
1-Tages-Spanne:
$4.89
$5.08
1-Wochen-Bereich:
$4.7825
$5.7373
52-Wochen-Spanne:
$3.94
$10.37
Alpha Teknova Inc Stock (TKNO) Company Profile
Firmenname
Alpha Teknova Inc
Sektor
Telefon
(831) 637-1100
Adresse
2451 BERT DRIVE, HOLLISTER
Vergleichen Sie TKNO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TKNO
Alpha Teknova Inc
|
5.01 | 265.44M | 36.68M | -36.78M | -26.75M | -1.16 |
|
ZTS
Zoetis Inc
|
142.26 | 62.54B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 43.30B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.08 | 40.08B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.02 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.06 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Alpha Teknova Inc Stock (TKNO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-22 | Fortgesetzt | Stephens | Overweight |
| 2025-02-10 | Eingeleitet | Craig Hallum | Buy |
| 2024-03-12 | Herabstufung | BTIG Research | Buy → Neutral |
Alpha Teknova Inc Aktie (TKNO) Neueste Nachrichten
Can volume confirm reversal in Alpha Teknova Inc.Risk Management & Free High Accuracy Swing Entry Alerts - newser.com
What insider trading reveals about Alpha Teknova Inc. stockWeekly Volume Report & Entry and Exit Point Strategies - newser.com
Using data filters to optimize entry into Alpha Teknova Inc.Watch List & Free Risk Controlled Daily Trade Plans - newser.com
How strong is Alpha Teknova Inc. stock balance sheet2025 Buyback Activity & Free Long-Term Investment Growth Plans - newser.com
How to use Fibonacci retracement on Alpha Teknova Inc.2025 EndofYear Setup & Precise Swing Trade Alerts - newser.com
Full technical analysis of Alpha Teknova Inc. stockWeekly Profit Report & Long-Term Safe Return Strategies - newser.com
Will Alpha Teknova Inc. see short term momentum2025 Sector Review & Real-Time Market Sentiment Reports - newser.com
Amedisys Inc Stock Analysis and ForecastMarket Liquidity Analysis & Big Profit Low Trading - earlytimes.in
Alpha Teknova (NASDAQ:TKNO) Given Sell (D-) Rating at Weiss Ratings - MarketBeat
Using data models to predict Alpha Teknova Inc. stock movement2025 Investor Takeaways & Capital Efficiency Focused Strategies - newser.com
Why Alpha Teknova Inc. stock could benefit from AI revolutionQuarterly Portfolio Review & Reliable Intraday Trade Plans - newser.com
Why Alpha Teknova Inc. stock could be next big winnerShare Buyback & Safe Entry Point Alerts - newser.com
Heatmap analysis for Alpha Teknova Inc. and competitorsStock Surge & Weekly High Return Stock Opportunities - newser.com
Momentum divergence signals in Alpha Teknova Inc. chartEarnings Growth Report & Growth Focused Stock Pick Reports - newser.com
Should you hold or exit Alpha Teknova Inc. now2025 Analyst Calls & Safe Entry Point Alerts - newser.com
Live market analysis of Alpha Teknova Inc.July 2025 Recap & Free Fast Gain Swing Trade Alerts - newser.com
Craig-Hallum Remains a Buy on Alpha Teknova (TKNO) - The Globe and Mail
Analyzing net buyer seller activity in Alpha Teknova Inc.Weekly Volume Report & Expert Approved Momentum Trade Ideas - newser.com
Teknova Rises On Custom Reagent Growth—But Profit Still Elusive - Finimize
Will Simbhaoli Sugars Limited Stock Continue to Outperform in YEARTechnical Resistance Breaks & Connect With Bulls, Avoid the Bears - earlytimes.in
Is Alpha Teknova Inc. a candidate for recovery play2025 Risk Factors & Smart Money Movement Alerts - newser.com
KeyBanc highlights supportive policy signals for cell and gene therapy stocks By Investing.com - Investing.com Nigeria
KeyBanc highlights supportive policy signals for cell and gene therapy stocks - Investing.com Nigeria
Finanzdaten der Alpha Teknova Inc-Aktie (TKNO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):